Search Results - "Lajmi, Nesrine"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients by Cao, Yanran, Luetkens, Tim, Kobold, Sebastian, Hildebrandt, York, Gordic, Maja, Lajmi, Nesrine, Meyer, Sabrina, Bartels, Katrin, Zander, Axel R, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje

    Published in Experimental hematology (01-10-2010)
    “…Objective The interaction of multiple myeloma (MM) with its bone marrow (BM) microenvironment is important for the homing pattern, survival, and proliferation…”
    Get full text
    Journal Article
  3. 3

    Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells by ATANACKOVIC, Djordje, HILDEBRANDT, York, GORDIC, Maja, STAHL, Tanja, ZANDER, Axel R, BOKEMEYER, Carsten, KRÖGER, Nicolaus, JADCZAK, Adam, CAO, Yanran, LUETKENS, Tim, MEYER, Sabrina, KOBOLD, Sebastian, BARTELS, Katrin, PABST, Caroline, LAJMI, Nesrine

    Published in Haematologica (Roma) (01-05-2010)
    “…Multiple myeloma is a life-threatening disease and despite the introduction of stem cell transplantation and novel agents such as thalidomide, lenalidomide,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma by ATANACKOVIC, Djordje, PANSE, Jens, LAJMI, Nesrine, ZANDER, Axel R, MARX, Andreas H, BOKEMEYER, Carsten, KRÖGER, Nicolaus, HILDEBRANDT, York, JADCZAK, Adam, KOBOLD, Sebastian, YANRAN CAO, TEMPLIN, Julia, MEYER, Sabrina, REINHARD, Henrike, BARTELS, Katrin

    Published in Haematologica (Roma) (01-10-2011)
    “…To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Cancer‐testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma by Lajmi, Nesrine, Luetkens, Tim, Yousef, Sara, Templin, Julia, Cao, Yanran, Hildebrandt, York, Bartels, Katrin, Kröger, Nicolaus, Atanackovic, Djordje

    Published in British journal of haematology (01-12-2015)
    “…Summary Cancer‐testis antigens belonging to the MAGE family of genes, such as MAGEC2, are commonly and specifically expressed in Multiple Myeloma (MM) and are…”
    Get full text
    Journal Article
  10. 10

    Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma by Yousef, Sara, Heise, Johanna, Lajmi, Nesrine, Bartels, Katrin, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje

    Published in Journal of translational medicine (20-06-2015)
    “…Most patients with multiple myeloma (MM) will relapse after an initial response and eventually succumb to their disease. This is due to the persistence of…”
    Get full text
    Journal Article
  11. 11

    Role of Interleukin 16 in Multiple Myeloma by ATANACKOVIC, Djordje, HILDEBRANDT, York, SEZER, Orhan, ZANDER, Axel R, MARX, Andreas H, UHLIG, Ria, ZUSTIN, Jozef, BOKEMEYER, Carsten, KRÖGER, Nicolaus, TEMPLIN, Julia, YANRAN CAO, KELLER, Christiane, PANSE, Jens, MEYER, Sabrina, REINHARD, Henrike, BARTELS, Katrin, LAJMI, Nesrine

    “…Multiple myeloma is a malignancy characterized by the expansion of a plasma cell clone that localizes to the human bone marrow. Myeloma cells and bone marrow…”
    Get full text
    Journal Article
  12. 12

    Abstract 4729: MAGE-C2 promotes proliferation and enhances resistance to p53 DNA damage-mediated apoptosis in multiple myeloma by Lajmi, Nesrine, Yousef, Sara, Luetkens, Tim, Templin, Julia, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Abstract Background: MAGE-C2 is member of the MAGE class I family of genes and is commonly and specifically expressed in Multiple Myeloma (MM). Expression of…”
    Get full text
    Journal Article
  13. 13

    An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body by Cao, Yanran, Gordic, Maja, Kobold, Sebastian, Lajmi, Nesrine, Meyer, Sabrina, Bartels, Katrin, Hildebrandt, York, Luetkens, Tim, Ihloff, Anna Sophie, Kröger, Nicolaus, Bokemeyer, Carsten, Atanackovic, Djordje

    Published in Journal of immunological methods (30-06-2010)
    “…In the framework of our current study we set out to develop an optimized assay for the quantification of antigen-specific B cells in different compartments of…”
    Get full text
    Journal Article
  14. 14

    Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma by Lajmi, Nesrine, Templin, Julia, Yousef, Sara, Luetkens, Tim, Spock, Stefanie, Hildebrandt, York, Bartels, Katrin, Cao, Yanran, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje

    Published in Blood (16-11-2012)
    “…Abstract 1808 Cancer-testis antigens belonging to the MAGE class I family of genes are commonly expressed in Multiple Myeloma (MM). Expression of MAGE class I…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Abstract 2450: Surface molecule CD229 represents a possible target for the treatment of multiple myeloma by Atanackovic, Djordje, Panse, Jens, Hildebrandt, York, Jadczak, Adam, Luetkens, Tim, Kobold, Sebastian, Lajmi, Nesrine, Zander, Axel R., Cao, Yanran, Bokemeyer, Carsten, Kroeger, Nicolaus

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract BACKGROUND AND OBJECTIVES: The majority of patients with multiple myeloma (MM) will eventually relapse and succumb to their disease even after high…”
    Get full text
    Journal Article
  17. 17
  18. 18

    NY-ESO-1 expression and immunogenicity in prostate cancer patients by Gati, Asma, Lajmi, Nesrine, Derouiche, Amine, Marrakchi, Raja, Chebil, Mohamed, Benammar-Elgaaied, Amel

    Published in Tunisie Medicale (01-10-2011)
    “…Prostate cancer is the second leading cause of men cancer-related death. Cancer immunotherapy has been investigated as a treatment which might be instituted at…”
    Get more information
    Journal Article
  19. 19
  20. 20